Inflammatory bowel disease patients show reduced pulmonary function, specifically in carbon monoxide transfer factor. This lung impairment is significant compared to healthy individuals and not clearly linked to sulfasalazine treatment.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: